These findings complement those of previous studies, which showed that liraglutide improved the ALT, AST, APRI, and histological features of patients with type 2 diabetes and NAFLD.8, 9, 10, 11. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.